Literature DB >> 12856091

Endovascular treatment of a cavernous sinus dural arteriovenous fistula by transvenous embolisation through the superior ophthalmic vein via cannulation of a frontal vein.

C Venturi1, S Bracco, A Cerase, P Gennari, F Lorè, E Polito, A E Casasco.   

Abstract

We describe a new approach for transvenous embolisation of cavernous sinus dural arteriovenous fistulae through the superior ophthalmic vein (SOV), i.e., via percutaneous cannulation of a frontal vein. Modern neurointerventional angiographic materials make it possible to reach the SOV in this way without puncturing it in the orbit or a surgical exposure. Orbital phlebography should still be in the repertoire of interventional neuroradiology units in large centres.

Entities:  

Mesh:

Year:  2003        PMID: 12856091     DOI: 10.1007/s00234-003-1020-2

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  18 in total

1.  [Treatment of spontaneous carotid-cavernous fistula by the transvenous approach via the facial and angular route].

Authors:  T Mizuno; Y Kai; T Todaka; M Morioka; J Hamada; Y Ushio
Journal:  No Shinkei Geka       Date:  2001-10

2.  Treatment of a cavernous sinus dural arteriovenous fistula by deep orbital puncture of the superior ophthalmic vein.

Authors:  G Benndorf; A Bender; A Campi; H Menneking; W R Lanksch
Journal:  Neuroradiology       Date:  2001-06       Impact factor: 2.804

3.  Long-term clinical outcome of spontaneous carotid cavernous sinus fistulae supplied by dural branches of the internal carotid artery.

Authors:  H M Liu; Y H Wang; Y F Chen; J S Cheng; P K Yip; Y K Tu
Journal:  Neuroradiology       Date:  2001-11       Impact factor: 2.804

4.  Superior petrosal sinus catheterization for transvenous embolization of a dural carotid cavernous sinus fistula.

Authors:  Charbel Mounayer; Michel Piotin; Laurent Spelle; Jacques Moret
Journal:  AJNR Am J Neuroradiol       Date:  2002-08       Impact factor: 3.825

5.  Facial Vein Approach by Direct Puncture at the Base of the Mandible for Dural Carotid-Cavernous Fistula. An alternative to the Superior Ophthalmic Vein Approach. A Case Report.

Authors:  I Naito; S Magarisawa; H Wada
Journal:  Interv Neuroradiol       Date:  2004-10-20       Impact factor: 1.610

6.  Occlusion of arteriovenous malformations of the cavernous sinus via the superior ophthalmic vein.

Authors:  M M Teng; W Y Guo; C I Huang; C C Wu; T Chang
Journal:  AJNR Am J Neuroradiol       Date:  1988 May-Jun       Impact factor: 3.825

7.  [Dural arterovenous fistula involving cavernous sinus].

Authors:  Z Yu; L Ma; M Yang; S Qin; G Xu; J Gong; J Hu; L Pan; G Yao; X Zhang
Journal:  Zhonghua Wai Ke Za Zhi       Date:  2000-02

Review 8.  Treatment of carotid-cavernous fistula by trans-venous anterior (trans-orbital) approach. Case report and review of previous report.

Authors:  V Iaccarino; R Spaziante; G Bonavolontà; S Cirillo; E De Divitiis
Journal:  J Neurosurg Sci       Date:  1993-06       Impact factor: 2.279

9.  Improvements in technique developed over a series of 500 orbital venograms--cavernous sinograms.

Authors:  P Macpherson
Journal:  Clin Radiol       Date:  1981-01       Impact factor: 2.350

10.  Management of cavernous sinus-dural fistulas. Indications and techniques for primary embolization via the superior ophthalmic vein.

Authors:  R A Goldberg; S H Goldey; G Duckwiler; F Vinuela
Journal:  Arch Ophthalmol       Date:  1996-06
View more
  10 in total

1.  Endovascular treatment for dural arteriovenous fistula of the anterior condylar vein with unusual venous drainage: report of two cases.

Authors:  Shuichi Tanoue; Katsuya Goto; Shinzo Oota
Journal:  AJNR Am J Neuroradiol       Date:  2005-09       Impact factor: 3.825

2.  Endovascular treatment of dural arteriovenous fistulae of the cavernous sinus via frontal veins.

Authors:  Guido Wilms; Sam Heye; Geert Maleux
Journal:  Neuroradiology       Date:  2006-03-07       Impact factor: 2.804

3.  Onyx embolization of dural arteriovenous fistulas of the cavernous sinus through the superior pharyngeal branch of the ascending pharyngeal artery.

Authors:  Guglielmo Pero; Luca Quilici; Mariangela Piano; Luca Valvassori; Edoardo Boccardi
Journal:  BMJ Case Rep       Date:  2014-04-23

4.  Transvenous embolization of intracranial dural arteriovenous shunts through occluded venous segments: experience in 51 Patients.

Authors:  E Lekkhong; S Pongpech; K Ter Brugge; P Jiarakongmun; R Willinsky; S Geibprasert; T Krings
Journal:  AJNR Am J Neuroradiol       Date:  2011-07-28       Impact factor: 3.825

Review 5.  Cavernous sinus dural arteriovenous fistula treated by facial vein direct puncture: Case report and review of the literature.

Authors:  Atsushi Matsumoto; Masanobu Okauchi; Atsushi Shindo; Masahiko Kawanishi; Takashi Tamiya
Journal:  Interv Neuroradiol       Date:  2017-01-01       Impact factor: 1.610

6.  Transvenous embolization of cavernous sinus dural arteriovenous fistula using the direct superior ophthalmic vein approach: a case report.

Authors:  Jong Geun Ha; Hae Woong Jeong; Hyun Sin In; Seok Jin Choi
Journal:  Neurointervention       Date:  2011-08-31

7.  Endovascular management of cavernous sinus dural arteriovenous fistulas: Overall review and considerations.

Authors:  Jong Min Lee; Eun Suk Park; Soon Chan Kwon
Journal:  J Cerebrovasc Endovasc Neurosurg       Date:  2021-12-17

8.  Cavernous sinus dural arteriovenous fistula accessed through a straightened superficial temporal vein.

Authors:  Teishiki Shibata; Yusuke Nishikawa; Takumi Kitamura; Mitsuhito Mase
Journal:  Surg Neurol Int       Date:  2021-12-30

9.  Transvenous Embolization of Cavernous and Paracavernous Dural Arteriovenous Fistula through the Facial Vein: Report of 12 Cases.

Authors:  Myeong Jin Kim; Yong Sam Shin; Yon Kwon Ihn; Byung Moon Kim; Pyeong Ho Yoon; Se-Yang Oh; Bum-Soo Kim
Journal:  Neurointervention       Date:  2013-02-28

Review 10.  Endovascular treatment of the cavernous sinus dural arteriovenous fistula: current status and considerations.

Authors:  Kun Hou; Guichen Li; Tengfei Luan; Kan Xu; Jinlu Yu
Journal:  Int J Med Sci       Date:  2020-05-01       Impact factor: 3.738

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.